However, there was no significant difference in tumor growth in Usp5 cKO mice between the control IgG and anti-PD-1 therapy group (Supplementary Fig. 10f, g), indicating that Usp5 deficiency reducing the PD-1 protein abundance might mimic PD-1 blockade. Here, USP5 is linked to neoplasm.